Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11628181 N4-hydroxycytidine and derivatives and anti-viral uses related thereto

Patent 11628181 was granted and assigned to Emory University on April, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Emory University

0

Current Assignee

Emory University

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Michael G. Natchus0

David Guthrie0

Gregory R. Bluemling0

George R. Painter0

Date of Patent

April 18, 2023

0

Patent Application Number

169213590

Date Filed

July 6, 2020

0

Patent Citations

US Patent 10100076 Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation

0

US Patent 10052342 Substituted nucleosides, nucleotides and analogs thereof

0

US Patent 10307439 Substituted nucleosides, nucleotides and analogs thereof

0

US Patent 10370401 Substituted nucleosides, nucleotides and analogs thereof

0

US Patent 10464965 Substituted nucleosides, nucleotides and analogs thereof

0

US Patent 10874683 N4-hydroxycytidine and derivatives and anti-viral uses related thereto

0

Patent Primary Examiner

Patrick T. Lewis

0

CPC Code

0

0

0

0

0

0

0

This disclosure relates to N4-hydroxycytidine derivatives, compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment and prophylaxis of viral infections.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11628181 N4-hydroxycytidine and derivatives and anti-viral uses related thereto

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool